1.
Lau P, Chin JL, Pautler S, Razvi H, Izawa JI. NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients. CUAJ [Internet]. 2013 May 1 [cited 2024 Apr. 27];3(6):454-8. Available from: https://cuaj.ca/index.php/journal/article/view/1173